• Tel. 900 101 549
  • +34 93 546 01 35
  • Facebook IOR
  • Twitter IOR
  • LinkedIn IOR
  • Hospital Universitari Dexeus
  • Centro Médico Teknon
  • Hospital Universitari General de Cataluña
  • Hospital Universitari Sagrat Cor

SCIENTIFIC PUBLICATIONS

Our medical oncologists and laboratory investigators are at the forefront of investigations into the causes of cancer and the search for novel treatments.

We have published the results of our investigations, often in collaboration with some of the most prestigious international institutions, in renowned medical journals such as the New England Journal of Medicine, Clinical Cancer Research, and many others.

CONSULT OUR SCIENTIFIC PUBLICATIONS

03/05/2014

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data

AUTHORS NSCLC Meta-analysis Collaborative Group inc. Rosell R

PUBLICATION The Lancet

READ ARTICLE

01/03/2014

Activating mutations cluster in the “molecular brake” regions of protein kinases and do not associate with conserved or catalytic residues

AUTHORS Molina-Vila MA, Nabau-Moretó N, Tornador C, Sabnis AJ, Rosell R, Estivill X, Bivona TG, Marino-Buslje C.

PUBLICATION Human Mutation

READ ARTICLE

01/03/2014

Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression

AUTHORS Noemi Reguart, Rafael Rosell, Felipe Cardenal, Andres F. Cardona, Dolores Isla, Ramon Palmero, et al. & Miguel Angel Molina, Miquel Taron

PUBLICATION Lung Cancer

READ ARTICLE

03/02/2014

The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial

AUTHORS Carlota Costa, Miguel Angel Molina-Vila, Ana Drozdowskyj, Anna Gimenez-Capitan, Jordi Bertran-Alamillo, Niki Karachaliou, Radj Gervais, Bartomeu Massuti, Jia Wei, Teresa Moran, Margarita Majem, Enriqueta Felip, Enric Carcereny, et al. & Rafael Rosell

PUBLICATION Clinical Cancer Research

READ ARTICLE

30/12/2013

Treatment of advanced non–small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic Oncology

AUTHORS Cesare Gridelli, Filippo de Marinis, Federico Cappuzzo, Massimo Di Maio, Fred R. Hirsch, Tony Mok, Floriana Morgillo, Rafael Rosell, David R. Spigel, et al.

PUBLICATION Clinical Lung Cancer

READ ARTICLE